1. Angelini Pharma
  2. From Pipeline to health aids
  3. Clinical Trials

Clinical trials

A clinical trial is any human study aimed at discovering or verifying the effects of a new drug or an existing drug tested for new ways of therapeutic use, with the aim of ensuring its safety or efficacy. The trial is divided into various phases and is carried out first in the laboratory and in animal models (preclinical experimentation) and then on humans (clinical studies). The information on this page concerns the clinical studies conducted by Angelini Pharma and is not for promotional purposes. 

Learn more about clinical studies on ClinicalTrials.gov. 

Study title: Efficacy and safety of different dosage regimens of the combination methocarbamol/paracetamol in acute Low Back Pain (LBP): MioPain study

  • Therapeutic areas: Consumer healthcare
  • Study phase: IV
  • Product code/study ID: 044(10A)MD20294
  • Drug substance: Other
  • Study type: Interventional
  • Study status: On-going

Study-related information

Results-related information

  • Study results: -
  • Scientific publication: -

Study title: A 12-month, prospective, observational study in adult patients with focal onset seizures who are treated with adjunctive AED in real world setting.

  • Therapeutic areas: Brain Health - Epilepsy
  • Study phase: NA
  • Product code/study ID: 169(A)MD21254
  • Drug substance: Cenobamate
  • Study type: Observational
  • Study status: On-going

Study-related information

  • ClinicalTrial.Gov: Click Here
  • EudraCT or CTIS: -

  • Global

Results-related information

  • Study results: -
  • Scientific publication: -

  • test

Study title: A randomized, two-way, crossover, two parallel groups study to compare the bioavailability of 150 mg and 300 mg trazodone hydrochloride tablets (new polymer) (Angelini Pharma S.p.A.) vs. 150 mg and 300 mg trazodone hydrochloride Contramid® tablets (Angelini Pharma S.p.A.) at steady-state

  • Therapeutic areas: Brain Health - Depression
  • Study phase: I
  • Product code/study ID: 039(C/a)MD23341
  • Drug substance: Trazodone
  • Study type: Interventional
  • Study status: Completed

Study-related information

Results-related information

  • Study results: -
  • Scientific publication: -

Study title: Efficacy of Trazodone Once-a-Day for treatment of Major Depressive Disorder in patients with breast cancer

  • Therapeutic areas: Brain Health - Depression
  • Study phase: IV
  • Product code/study ID: 039(C)MD21046
  • Drug substance: Trazodone
  • Study type: Interventional
  • Study status: On-going

Study-related information

Results-related information

  • Study results: Click Here
  • Scientific publication: -

Study title: Retrospective observational study on the use of cenobamate in a cohort of patients suffering from epilepsy and prescribed during the Early Access Program (EAP) in Germany, France and UK

  • Therapeutic areas: Brain Health - Epilepsy
  • Study phase: NA
  • Product code/study ID: 169(A)MD21350
  • Drug substance: Cenobamate
  • Study type: Observational
  • Study status: Completed

Study-related information

  • ClinicalTrial.Gov: click here
  • EudraCT or CTIS: -

  • Global

Results-related information

  • Study results: -
  • Scientific publication: - Click Here

Legend

  • On-going: The study has been submitted to authority
  • Completed: The procedures set forth by the study protocol have been completed
  • Terminated: The study has been terminated prematurely